— Zebra Technologies Corporation (NASDAQ: ZBRA) reported adjusted earnings of $3.56 per share for the fourth quarter of 2019, vs. $3.65 per share expected.
— Net income increased to $169 million or $3.10 per share from $115 million or $2.11 per share in the fourth quarter of 2018
— At $1.19 billion, fourth-quarter net sales were up 4.8% year-over-year, vs. $1.2 billion expected
— Adjusted EBITDA increased 6.3% annually to $255 million during the three-month period
— Expects first-quarter 2020 net sales to increase 4%-7% year-over-year, which includes one percentage point additive impact from acquisitions
— First-quarter adjusted EBITDA margin is expected to be 20%; adjusted earnings are expected to be in the range of $2.90 per share to $3.10 per share
— Expects full-year 2020 net sales to rise 4%-6% from last year, which includes about 30 basis point positive impact from acquisitions
— Full-year adjusted EBITDA margin is expected to be slightly above 22%; looking to generate free cash flow of at least $700 million in 2020
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
